Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Vaccines Logo (drop shadow)

PART OF NEXTGEN BIOMED 2026

24 - 25 March 2026 | QEII Centre, London, UK

Programme Summary

Delve into the latest in vaccines R&D:  from advanced nucleotide-based platforms for infectious diseases, to antigen development, vaccine analytics & pre-clinical and clinical development for mRNA vaccines.

Hear from past attendees of the NextGen Biomed 2025 conference

DAY TWO

Keynote Address

SIR MARC FELDMANN AC, FRS, Emeritus Professor, University of Oxford

Sir Marc Feldmann is a pioneering immunologist whose groundbreaking discovery that
blocking TNF-a could stop the destructive inflammation of rheumatoid arthritis laid
the foundation for modern immunotherapy.

His work directly led to the development of anti-TNF drugs, now life-changing treatments for millions of patients with autoimmune diseases worldwide. Widely recognized as one of the founders of immunotherapy, he has been honoured with the Lasker Award, Crafoord Prize, Tang Prize, and a knighthood for his transformative contributions to medicine.

2026 Highlights

See how AI is revolutionising vaccine R&D—from rapid antigen discovery and rational
design to smarter manufacturing, streamlined clinical trials, and regulatory-ready
development—delivering faster, more effective vaccines to patients worldwide.

NextGen Biomed - What to Expect Presenting 1
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments
NGB + LSX Combined Logo-1

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.

NGB Newsletter Icon-1

Meet Our Expert Speakers

Vaccines again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Paul Kellam
Chief Scientific Officer,
RQ Bio
Show More Speakers
Hide Speakers
Adam Williams
Senior Director, Vaccines Commercial Development & Pandemic Preparedness,
Pfizer
Aleksandra Moleda
CMC Regulatory Manager,
Scancell
Brian Weinert
Principal Scientist & Discovery Project Lead,
Nykode Therapeutics
Brian Schanen
Global Head of Biomarkers,
Sanofi
Ebru Dogruol
Commercial Vice President, Vaccines and mRNA Emerging Markets,
Pfizer Ltd
Gry Persson
Project Manager, Team Leader, & Working Environment Manager,
Evaxion
Heinrich Haas
Chief Technology Officer,
Neovacs
Joanna Calvert
Senior Programme Manager - UK Vaccine Innovation Pathway,
NIHR
Joel Benjamin Heim
Senior Project Manager,
Nykode Therapeutics
Manuel Vega
Chief Executive Officer,
AGS Therapeutics
Marc Siggel
Research Scientist,
Merck & Cie KmG
Michael Anyadiegwu
CMC Technology Lead,
CEPI
Noémie Caillot
Immunology Scientist,
Sanofi Pasteur
Prasun Chakraborty
Founder & CEO,
Genevation LTD
Rikhav Gala
Principal Scientist,
Pfizer Ltd
Robb Butler
Director, Division of Communicable Diseases Environment and Health,
World Health Organisation
Sue Charlton
Head of Clinical Evaluation,
UK Health Security Agency
Supriyadi Hafiz
Senior Scientist,
Merck
Tobias Von Der Haar
Professor,
University of Kent
Veronika Jotterand
Medical Director, Global Clinical Development, Vaccines,
MSD
Yongqun He
Professor,
University of Michigan

Vaccines Agenda at a Glance

Three immersive tracks across two days

DAY ONE - 25 MARCH

Track 11: Vaccine Platforms & AI-Driven Design Approaches 

DAY TWO - 26 MARCH

Track 10: Translational & Clinical & AI-Driven Vaccine Development  
Track 11: Vaccine Analytics, Stability & Delivery for Infectious Diseases  

 

NextGen Biomed Conference Brochure

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Register Now

Be part of the new wave of Biomed R&D innovation

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients